Dompé is an Italian biopharmaceutical company based in Milan with US headquarters in the San Francisco Bay Area. It is committed to innovation, pursuing solutions to unmet medical needs in ophthalmology, transplants, oncology and diabetes. Dompé’s commitment to ophthalmology includes the first topical biologic FDA-approved for an ophthalmic indication.
Brands: Oxervate